CLINICAL_TRIALS
withdrawal
· 2012-08-22
Clinical Trial Update: Safety and Preliminary Efficacy Study of PDS-1.0 in Patients With Neovascular AMD [Phase 1]
Summary
A Phase 1 safety and preliminary efficacy trial of PDS-1.0 for neovascular age-related macular degeneration has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forsight Vision4 | Conditions: Age-Related Macular Degeneration | Phase 1 | Status: WITHDRAWN